KeyBanc initiates NiSource stock coverage with overweight rating By Investing.com

KeyBanc initiated NiSource (NI) with an overweight and $52 price target (~12% above the $46.50 share price). Q4 2025 adjusted EPS was $0.51 versus a $0.50 forecast (slight beat) while revenue missed materially at $1.2B vs $1.49B expected (~19.5% shortfall). The board declared a $0.30 quarterly dividend payable May 20, 2026 (record Apr 30, 2026); KeyBanc cites constructive regulatory environments supporting a ~1.5x premium valuation even as InvestingPro flags the stock as overvalued and four analysts have raised earnings estimates.

Analysis

NI’s current multiple appears to price a multi-year regulatory premium — not just the next rate case — which makes the stock highly sensitive to yield moves and discrete regulator outcomes. A 25–75bp swing in allowed ROE or in Treasury yields should move the equity by low-double to mid-teens percentage points within a 3–12 month window because regulated cash flows are long-duration and small spread changes compound against a large rate base.

Second-order beneficiaries include capex vendors and engineering contractors that service steady regulated programs; conversely, merchant-exposed parts of utilities or peers with longer regulatory lag are vulnerable if investors re-rate the cohort toward faster-earning regulated names. Market positioning is likely crowded (income-seeking funds + buy-and-hold retail), which amplifies volatility around rate-case decisions or any signal of capital-expenditure overruns.

Key tail risks are regulatory disappointment (reduced allowed returns or longer lag), step-up capex that compresses near-term FCF, and a sustained move higher in real rates that narrows utility multiples. Near-term catalysts to monitor: published rate-case filings/decisions, state commission testimony transcripts, and any revision cycles from analysts — each can produce 5–15% moves in weeks rather than months.

Key Decisions for Investors

• Tactical long: Buy NI shares up to $47 with a 6–12 month horizon targeting $52; set a protective stop at $41.50 (approx -10%). Rationale: conviction on regulatory premium but respect for rate/commission risk — R/R ~1.5:1.
• Idiosyncratic pair: Long NI / short XLU equal-dollar notional for 3–9 months to isolate company-specific regulatory re-rating. Exit on a 10% spread move or after the next rate-case decision; this reduces beta to interest-rate moves while capturing repricing risk.
• Defined-risk option: Buy a 6–9 month NI call spread (near ATM to 10% OTM) sized to risk no more than 2% of book. Use this into known catalyst dates (rate-case filings, commission votes) to lever upside while capping downside.
• Hedge against regime shift: If worried about broader rate shock, trim NI exposure and buy short-dated interest-rate protection (e.g., increase allocation to cash/T-bills or buy duration-sensitive put protection via an ETF) until rate path clarity returns — preserves optionality without giving up yield.